These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
630 related items for PubMed ID: 7514366
1. Risperidone in the treatment of schizophrenia. Marder SR, Meibach RC. Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366 [Abstract] [Full Text] [Related]
4. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Peuskens J. Br J Psychiatry; 1995 Jun; 166(6):712-26; discussion 727-33. PubMed ID: 7545060 [Abstract] [Full Text] [Related]
6. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Cesková E, Svestka J. Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306 [Abstract] [Full Text] [Related]
7. Risperidone in treatment-refractory schizophrenia. Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC. Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947 [Abstract] [Full Text] [Related]
8. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB. Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505 [Abstract] [Full Text] [Related]
9. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study. Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S. Acta Psychiatr Scand; 1992 Apr; 85(4):295-305. PubMed ID: 1375801 [Abstract] [Full Text] [Related]
10. Negative symptoms in schizophrenia: assessment of the effect of risperidone. Schooler NR. J Clin Psychiatry; 1994 May; 55 Suppl():22-8. PubMed ID: 7520905 [Abstract] [Full Text] [Related]
13. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W. Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [Abstract] [Full Text] [Related]
14. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia. Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD. J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910 [Abstract] [Full Text] [Related]
15. Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial. Min SK, Rhee CS, Kim CE, Kang DY. Yonsei Med J; 1993 Jun; 34(2):179-90. PubMed ID: 7691017 [Abstract] [Full Text] [Related]
16. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol]. López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A. Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 Jun; 24(4):165-72. PubMed ID: 8984849 [Abstract] [Full Text] [Related]
17. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. Czobor P, Volavka J. J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770 [Abstract] [Full Text] [Related]
18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]